Stroke. 2007;38:1999-2000
Published online before print April 19, 2007,
doi: 10.1161/STROKEAHA.107.482687
(Stroke. 2007;38:1999.)
© 2007 American Heart Association, Inc.
Electromyographic Biofeedback for the Recovery of Motor Function After Stroke
Henry J. Woodford, BSc, MRCP
Christopher Price, MD, MRCP
From the Cumberland Infirmary (H.J.W.), Cumbria, UK; and the Northumbria Healthcare Trust (C.P.), Northumberland, UK.
Correspondence to Henry J. Woodford, Cumberland Infirmary, Newtown Rd, Carlisle, Cumbria, UK CA2 7HY. E-mail henry.woodford@ncumbria-acute.nhs.uk
Graeme J. Hankey MD, FRCP Section Editor:
Key Words: biofeedback EMG physiotherapy rehabilitation stroke stroke recovery
An extract of the first 250 words of the full text is provided, because this article has no abstract.
|
 |
Introduction
|
|---|
The specific objective of this review was to determine the efficacy
of any form of electromyographic biofeedback (EMG-BFB) used
after a stroke in order to aid motor function recovery.
 |
Search Strategy
|
|---|
We searched the Cochrane Stroke Group Trials Register (last
searched March 30, 2006), the Cochrane Central Register of Controlled
Trials (CENTRAL; The Cochrane Library Issue 4, 2005), MEDLINE
(1966 to November 2005), EMBASE (1980 to November 2005), CINAHL
(1983 to November 2005), PsycINFO (1974 to November 2005) and
First Search (1966 to November 2005). We scanned reference lists
for relevant articles and contacted equipment manufacturers
and distributors
 |
Selection Criteria
|
|---|
Randomized and quasirandomized studies comparing EMG-BFB with
control for motor function recovery in stroke patients.
 |
Data Collection & Analysis
|
|---|
Two review authors independently assessed trial quality and
extracted data. Where possible we contacted study authors for
further information. Any reported adverse effects were noted.
 |
Main Results
|
|---|
Thirteen trials involving 269 people were included. All trials
compared EMG-BFB plus standard physiotherapy to standard physiotherapy
either alone or with sham EMG-BFB. Only 1 study used a motor
strength assessment scale for evaluation of patients, which
indicated benefit from EMG-BFB (weighted mean difference 1.09;
95% CI, 0.48 to 1.70). EMG-BFB did not have a significant benefit
in improving range of motion through the ankle (standardized
mean difference 0.05; 95% CI, –0.36 to 0.46), knee or
wrist joints. However, 1 trial suggested a benefit in range
of motion at the shoulder (standardized mean difference 0.88;
95% CI, 0.07 to 1.70). Change in stride length or gait speed
was not improved by EMG-BFB. Two studies
. . . [Full Text of this Article]